A Multicenter, Double-Blind, Randomized, Placebo Controlled Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO4389620 in Patients with Type 2 Diabetes Mellitus Treated with a Stable Dose of Metformin